Cargando…
Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options
After cisplatin-based chemotherapy became the standard treatment for metastatic urothelial cancer (mUC), very little progress has been made in the treatment landscape of this condition until recently. With increased knowledge about the molecular biology of mUC and advances in the field of cancer imm...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Internal Medicine
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373963/ https://www.ncbi.nlm.nih.gov/pubmed/32668516 http://dx.doi.org/10.3904/kjim.2020.204 |